Skip to main content

BIOTRICITY INC

For the period ended Mar 31, 2024. Filed Jun 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jun 27, 2024

BTCY$0.14+7.5%Stored close · as of Jul 8, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the day of June 25, 2024.

BIOTRICITY INC.
By:/s/ Waqaas Al-Siddiq
Waqaas Al-Siddiq
Chief Executive Officer and President

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Waqaas Al-SiddiqChairman, President and Chief Executive Officer (principal executive officer)June 25, 2024
Waqaas Al-Siddiq
/s/ John AyanoglouChief Financial Officer (principal financial and accounting officer)June 25, 2024
John Ayanoglou
/s/ David A. RosaDirectorJune 25, 2024
David A. Rosa
/s/ Chester WhiteDirectorJune 25, 2024
Chester White
/s/ Ronald McClurgDirectorJune 25, 2024
Ronald McClurg

Biotricity Inc.

For the years ended March 31, 2024 and 2023

Table of Contents

Report of Independent Registered Public Accounting Firm (PCAOB ID: 5828)F-1
Consolidated Financial Statements for the years ended March 31, 2024 and 2023:
Consolidated Balance SheetsF-3
Consolidated Statements of Operations and Comprehensive LossF-4
Consolidated Statements of Mezzanine Equity and Stockholders’ DeficiencyF-5
Consolidated Statements of Cash FlowsF-6
Notes to Consolidated Financial StatementsF-7 - F-39
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.